Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Trial Evaluating Outcomes of FoundationOne - Directed Matched Targeted Therapy in Patients With Cancer of Unknown Primary (CUP)

NCT02628379 is registered in ClinicalTrials.gov with Foundation Medicine as lead sponsor.

NCT NCT02628379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02628379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Trial Evaluating Outcomes of FoundationOne - Directed Matched Targeted Therapy in Patients With Cancer of Unknown Primary (CUP)
Lead sponsor
Foundation Medicine
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
March 31, 2017
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cup, metastatic disease, neoplasms, unknown primary, poorly differentiated adenocarcinoma, poorly differentiated carcinoma, squamous carcinoma poorly differentiated